There are three flu vaccines specifically engineered for adults 65 and older, and the CDC preferentially recommends all three over the standard-dose shot. They are Fluzone High-Dose, which packs four times the antigen of a regular flu vaccine; Fluad Adjuvanted, which uses a compound called MF59 to amplify the immune response; and Flublok Recombinant, which contains triple the antigen and is completely egg-free. If you or someone you care for is over 65, these are the shots worth asking about by name at the pharmacy counter — not the same vaccine handed to a healthy 30-year-old. The reason these enhanced vaccines exist is straightforward and sobering.
During the 2024-2025 flu season, adults 65 and older accounted for 57% of all flu hospitalizations and 71% of all flu deaths in the United States. That season was classified as high severity by the CDC, with an estimated 51 million illnesses, 710,000 hospitalizations, and 45,000 deaths nationwide. The aging immune system simply does not mount as strong a defense against influenza, which is why a standard-dose vaccine often falls short for this age group. The rest of this article breaks down how each of the three preferred vaccines works, what the clinical data actually shows, how much they cost, and when to schedule the shot for maximum protection heading into the 2025-2026 season.
Table of Contents
- Why Is There a Special Flu Shot Made for People Over 65?
- Comparing the Three Enhanced Flu Vaccines — Fluzone High-Dose, Fluad, and Flublok
- The Real-World Toll of Flu on Older Adults and Why Vaccination Coverage Matters
- When to Get the Enhanced Flu Shot and Why Timing Matters More for Seniors
- Side Effects of Enhanced Flu Vaccines — What to Expect and When to Be Concerned
- What the Enhanced Flu Shot Costs and How to Get It Covered
- Looking Ahead to the 2025-2026 Flu Season
- Conclusion
- Frequently Asked Questions
Why Is There a Special Flu Shot Made for People Over 65?
The short answer is immunosenescence — the gradual decline in immune function that comes with aging. When a younger adult receives a standard-dose flu vaccine, their immune system generally produces a robust antibody response. In someone over 65, that same dose often triggers a weaker response, leaving them more vulnerable even after vaccination. This is not a minor gap. During the 2024-2025 season, the peak hospitalization rate for adults 65 and older hit 49.9 per 100,000 population, the highest of any age group. The standard flu shot, while still better than nothing, was not designed with that biological reality in mind. Enhanced vaccines address this by either increasing the amount of antigen (the component that teaches the immune system to recognize the virus) or by adding an adjuvant — a substance that jolts the immune system into a stronger response.
Think of it like the difference between whispering a warning and shouting it. For someone whose hearing has diminished, the louder signal matters. A landmark clinical trial of roughly 32,000 adults 65 and older found that Fluzone High-Dose was 24% more effective at preventing flu than the standard-dose version. That is not a marginal improvement. For a population that accounts for nearly three-quarters of flu deaths, it represents thousands of lives. It is also worth noting that the CDC does not merely list these three vaccines as acceptable alternatives. The Advisory Committee on Immunization Practices specifically and preferentially recommends them over standard-dose shots for this age group. If your pharmacy or doctor’s office tries to administer a regular flu vaccine to someone 65 or older without discussing these options, that is worth pushing back on.
Comparing the Three Enhanced Flu Vaccines — Fluzone High-Dose, Fluad, and Flublok
Fluzone High-Dose, manufactured by Sanofi, is the most well-known of the three. It contains four times the antigen of a standard flu shot, and it was the first vaccine FDA-licensed specifically for people 65 and older. The clinical evidence behind it is solid — that 24% efficacy advantage came from a large, randomized controlled trial, which is the gold standard in medical research. If you have no egg allergy and want the option with the most direct clinical trial data in the senior population, Fluzone High-Dose is a strong default choice. Fluad Adjuvanted, made by CSL Seqirus, takes a different approach. Rather than simply loading more antigen, it includes MF59, a squalene-based oil-in-water adjuvant that stimulates the immune system to respond more aggressively to the vaccine. Observational studies among Medicare beneficiaries 65 and older found that Fluad provided greater protection against flu-related hospitalizations and emergency room visits compared to standard-dose vaccines.
A separate study in nursing home residents — a particularly vulnerable group — showed lower risk of hospitalization for pneumonia and flu versus the standard dose. However, because most of the Fluad evidence comes from observational studies rather than head-to-head randomized trials against the other enhanced vaccines, it is harder to say definitively whether it outperforms Fluzone High-Dose or Flublok. The CDC considers all three preferentially recommended and does not rank them against one another. Flublok Recombinant, also from Sanofi, contains three times the antigen of standard vaccines and has a distinct advantage: it is entirely egg-free. It is manufactured using recombinant technology, meaning no egg protein is involved at any stage of production. For the significant number of older adults with egg allergies, this removes a barrier entirely. In March 2025, the FDA expanded Flublok’s approval to ages 9 and older, though its enhanced-dose formulation remains most relevant for the 65-plus population. A retrospective study of 12.7 million adults 65 and older found it more effective at preventing hospital visits than standard-dose vaccines. The limitation to be aware of is that Flublok’s three-times antigen level is lower than Fluzone High-Dose’s four-times level, though direct head-to-head comparison data between the two in seniors is limited.
The Real-World Toll of Flu on Older Adults and Why Vaccination Coverage Matters
Statistics can feel abstract until you consider what they mean in practice. The CDC estimates that during the 2024-2025 flu season, 81% of deaths prevented by vaccination were among people 65 and older. That figure was driven by two factors working together: a 44% vaccine effectiveness rate against hospitalizations in that age group, combined with a 63% vaccination coverage rate. In other words, nearly two-thirds of seniors got the shot, and even with moderate effectiveness, the sheer volume of prevented hospitalizations and deaths was enormous. But flip those numbers around and the gaps become clear. If 63% of adults 65 and older were vaccinated, that means 37% were not. Among those who remained unvaccinated, the consequences were disproportionately severe.
Adults 65 and older had the highest peak hospitalization rate of any age group at 49.9 per 100,000. For caregivers of people with dementia or other cognitive conditions, this carries an additional layer of risk — a flu hospitalization can trigger delirium, accelerate cognitive decline, and disrupt carefully maintained routines and care plans. The flu itself may resolve in a week, but the downstream effects on brain health can last months. Consider a 78-year-old with mild cognitive impairment living at home with a spouse. A week-long hospitalization for flu-related pneumonia means unfamiliar surroundings, disrupted sleep, potential sedating medications, and separation from their primary caregiver. Studies have consistently shown that hospitalization in older adults with cognitive vulnerability can accelerate the trajectory toward dementia. Preventing the flu is not just about avoiding a miserable week — it is about protecting the brain.
When to Get the Enhanced Flu Shot and Why Timing Matters More for Seniors
The CDC recommends that most people get vaccinated in mid-September or October. The vaccine takes approximately two weeks to become fully effective, so getting the shot in early October means protection is in place before flu activity typically peaks between December and February. This timing advice applies to the general population, but it carries extra weight for older adults. Specifically, the CDC advises that older adults should avoid getting vaccinated too early — meaning July or August. The reason is that immunity from the flu vaccine can wane faster in people over 65, potentially leaving them less protected during the tail end of flu season in February and March. A person who got vaccinated in late July might see their antibody levels drop meaningfully by the time a late-season wave hits.
This is a real tradeoff: getting vaccinated too early risks fading protection, while waiting too long risks getting caught unprotected during an early surge. The mid-September to October window represents the best balance for most seniors. If for some reason you miss that window, getting vaccinated later — even in December or January — is still far better than skipping it altogether. For caregivers managing a household where someone has dementia, it is worth vaccinating everyone in the home during that same window. Flu spreads easily in close quarters, and the person with dementia may not reliably report early symptoms like body aches or fatigue. Household-level protection is the most practical defense.
Side Effects of Enhanced Flu Vaccines — What to Expect and When to Be Concerned
The enhanced vaccines do come with slightly more frequent side effects compared to standard-dose shots. The most common are injection site pain, muscle aches, tiredness, and headache. These typically appear within three days of vaccination and resolve within three days. For most people, this amounts to a sore arm and feeling a bit run down for a day or two — uncomfortable but manageable. The key concern for caregivers of older adults, particularly those with dementia, is distinguishing vaccine side effects from something more serious.
If a person with cognitive impairment becomes unusually fatigued or complains of body aches within 48 hours of vaccination, that is almost certainly a normal and expected reaction. However, if symptoms persist beyond four or five days, or if a high fever develops, that warrants a call to the doctor. It is also worth noting that people who had a severe allergic reaction to a previous flu vaccine should discuss this with their physician before receiving any flu shot, enhanced or otherwise. One limitation worth acknowledging: the higher antigen load in Fluzone High-Dose and Flublok, and the adjuvant in Fluad, are specifically what cause the slightly elevated side-effect rate. You cannot get the enhanced immune response without the enhanced stimulation. This is a reasonable tradeoff for a population where flu carries a 71% share of all flu deaths, but it is still worth setting expectations in advance — especially for someone with dementia who may become distressed by unexpected soreness or fatigue without understanding why.
What the Enhanced Flu Shot Costs and How to Get It Covered
Cost should not be a barrier for most older adults. Medicare Part B covers flu shots at no cost when administered by an in-network provider. Most Medicare Advantage plans, Medicaid, and private insurance plans also cover the vaccine at zero copay. For the majority of adults 65 and older, walking into a pharmacy or doctor’s office and requesting Fluzone High-Dose, Fluad, or Flublok should result in no out-of-pocket expense.
For those without insurance — a situation that is less common among the 65-plus population but does occur — the retail price of Fluzone High-Dose runs approximately $130. However, GoodRx coupons can bring that cost down to around $62.50, which is worth checking before paying full price. Pharmacies like CVS, Walgreens, and most grocery store pharmacies carry at least one of the three enhanced options, though availability can vary by location, especially later in the season when supply runs low. Calling ahead to confirm they have the specific enhanced vaccine in stock is a practical step that saves a wasted trip.
Looking Ahead to the 2025-2026 Flu Season
All flu vaccines for the 2025-2026 season are trivalent, meaning they protect against three virus strains: an A(H1N1) virus, an A(H3N2) virus, and a B/Victoria lineage virus. This is a shift from previous years when quadrivalent vaccines — covering four strains — were the norm. The change reflects the fact that one of the two influenza B lineages has not circulated in years, making the fourth component unnecessary.
For older adults and their caregivers, the actionable takeaway remains the same: request one of the three enhanced vaccines by name when the 2025-2026 formulations become available, aim for mid-September to October, and make sure everyone in the household is vaccinated during that same window. The flu may seem like a routine illness, but for someone over 65 — and especially for someone living with cognitive decline — it is anything but routine. The right vaccine, given at the right time, remains one of the simplest and most effective protective measures available.
Conclusion
Three flu vaccines — Fluzone High-Dose, Fluad Adjuvanted, and Flublok Recombinant — are specifically designed and preferentially recommended by the CDC for adults 65 and older. They work by delivering more antigen or by including an adjuvant that amplifies the immune response, addressing the natural decline in immune function that makes older adults disproportionately vulnerable. The clinical evidence behind these vaccines is substantial, and during the devastating 2024-2025 season, vaccinated seniors accounted for the vast majority of prevented deaths.
If you are caring for someone over 65, especially someone with dementia or cognitive impairment, getting the right flu shot is one of the most straightforward steps you can take to avoid a hospitalization that could have cascading effects on brain health and daily function. Ask for one of the three enhanced vaccines by name, schedule it for mid-September or October, confirm that Medicare or insurance covers it at no cost, and vaccinate everyone in the household. The flu does not send a warning before it arrives — preparation is the only reliable defense.
Frequently Asked Questions
Can my doctor give me a standard flu shot instead of the enhanced version if the enhanced ones are unavailable?
Yes. The CDC says that if none of the three preferred vaccines are available, a standard-dose flu shot is still appropriate for adults 65 and older. Any flu vaccine is better than none. However, it is worth calling other pharmacies in your area before settling for the standard dose, since most large pharmacy chains stock at least one enhanced option.
Is one of the three enhanced vaccines better than the others?
The CDC does not rank them. Each has a different mechanism — higher antigen dose, an immune-boosting adjuvant, or recombinant manufacturing — and all are considered preferable to standard-dose vaccines for adults 65 and older. If you have an egg allergy, Flublok is the clear choice since it is entirely egg-free.
Can someone with dementia safely receive the high-dose flu vaccine?
Dementia itself is not a contraindication for any flu vaccine, including the enhanced versions. The primary concern is managing the brief side effects — soreness, fatigue, mild headache — in someone who may not be able to communicate what they are feeling. Caregivers should watch for signs of discomfort in the two to three days following vaccination.
Does the flu vaccine protect against COVID-19 or other respiratory illnesses?
No. The flu vaccine protects only against influenza viruses. It does not protect against COVID-19, RSV, or other respiratory infections. Older adults should discuss separate vaccines for COVID-19 and RSV with their healthcare provider, as these can be administered during the same visit in many cases.
What if my family member got vaccinated in August — should they get a second dose in the fall?
The CDC does not recommend a second dose for people who were vaccinated early. However, the concern about waning immunity in older adults vaccinated in July or August is real. Discuss with your doctor whether a second dose makes sense in your specific situation, as this is an area where individual medical advice matters more than general guidelines.
